Jurij Petrin joined BeiGene in 2021 and currently serves as Head of New Market Development. Before joining BeiGene, he served more than three years as Senior Vice President of Global Regulatory Affairs at the contract research organization PRA Health Sciences. He previously founded two companies, Pharmaceutical Regulatory Services, a regulatory consultancy; and PRS Clinical, a CRO. While running PRS and PRS Clinical, he established a network of regulatory and clinical/medical consultants and CROs in more than 90 countries, providing strategic regulatory, clinical, and product registration support to many products in various stages of development worldwide.

Earlier in his career, Dr. Petrin spent more than nine years at Bristol Myers Squibb as Medical Director for Central and Eastern Europe, Executive Director of International Regulatory Affairs, and Vice President of Intercontinental Regulatory Science. He has also served as a consultant to PhRMA on regulatory and market-introduction policy issues for Asia Pacific, with a focus on regulatory agencies in China, Japan, South Korea, Singapore, and Malaysia.

He received his M.D. from the University of Ljubljana, Slovenia, and completed a research fellowship at the University of Michigan.